# Helicobacter Pylori Resistance

> **NCT05019586** · — · COMPLETED · sponsor: **University Hospital of North Norway** · enrollment: 185 (actual)

## Conditions studied

- Helicobacter Pylori Resistance

## Interventions

- **DRUG:** levofloxacin, amoxicillin, clarithromycin

## Key facts

- **NCT ID:** NCT05019586
- **Lead sponsor:** University Hospital of North Norway
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04-15
- **Primary completion:** 2020-07-10
- **Final completion:** 2020-07-10
- **Target enrollment:** 185 (ACTUAL)
- **Last updated:** 2021-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05019586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05019586, "Helicobacter Pylori Resistance". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05019586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*